rhTNK-tPA Thrombolytic Removal of Intraventricular Hemorrhage
NCT06814964
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Intraventricular Hemorrhage
Interventions
DRUG:
Low dose group
DRUG:
Medium dose group
DRUG:
High dose group
Sponsor
Beijing Tiantan Hospital